{"id":522578,"date":"2026-01-17T10:45:14","date_gmt":"2026-01-17T10:45:14","guid":{"rendered":"https:\/\/www.europesays.com\/us\/522578\/"},"modified":"2026-01-17T10:45:14","modified_gmt":"2026-01-17T10:45:14","slug":"half-of-glp-1-users-ditch-their-injections-and-some-are-turning-to-other-weight-loss-methods-instead-marketwatch","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/522578\/","title":{"rendered":"Half of GLP-1 users ditch their injections \u2014 and some are turning to other weight-loss methods instead – MarketWatch"},"content":{"rendered":"
    \n
  1. Half of GLP-1 users ditch their injections \u2014 and some are turning to other weight-loss methods instead<\/a>  MarketWatch<\/li>\n
  2. What Happens When You Stop Taking a GLP-1 Drug?<\/a>  AARP<\/li>\n
  3. The Truth About Weight-Loss Drugs Like Ozempic: You Probably Need Them Forever<\/a>  The New York Times<\/li>\n
  4. Is the Worm Turning on ‘Fat Jabs’?<\/a>  BBC<\/li>\n
  5. Thursday’s Daily Dose with Monica Robins: Weight gain common after stopping GLP-1<\/a>  WKYC<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Half of GLP-1 users ditch their injections \u2014 and some are turning to other weight-loss methods instead  MarketWatch What…\n","protected":false},"author":3,"featured_media":522579,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[51288,232437,62222,190234,57,127462,210,1141,1165,18302,217416,178482,748,1060,149193,232435,232436,427,152,26524,232434,3234,190263,5660,67,132,68,2402,26011,121957,223022,180968,15208],"class_list":{"0":"post-522578","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-boston-scientific-corp","9":"tag-bsx","10":"tag-eli-lilly-co","11":"tag-gcapi","12":"tag-general-news","13":"tag-glp1","14":"tag-health","15":"tag-health-care","16":"tag-lifestyle","17":"tag-living","18":"tag-living-lifestyle","19":"tag-lly","20":"tag-manufacturing","21":"tag-medication","22":"tag-mental-fitness","23":"tag-novo-nordisk-a-s-adr","24":"tag-nvo","25":"tag-ozempic","26":"tag-pharmaceuticals","27":"tag-physical","28":"tag-physical-mental-fitness","29":"tag-political","30":"tag-political-general-news","31":"tag-synd","32":"tag-united-states","33":"tag-unitedstates","34":"tag-us","35":"tag-wegovy","36":"tag-weight-management","37":"tag-weightloss","38":"tag-ww","39":"tag-ww-international-inc","40":"tag-zepbound"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/522578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=522578"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/522578\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/522579"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=522578"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=522578"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=522578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}